Common anti-COVID-19 drugs and their anticipated interaction with anesthetic agents
The corona virus disease 2019 (COVID-19) pandemic has till date (26/7/20) affected 1crore 62 lac 73 thousand 638 people globally with almost 6.5 lakh mortalities. COVID-19 has invaded the operation theatre and intensive care unit (ICU) in a short span of 6 months. It appears inevitable that all of u...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Journal of Anaesthesiology Clinical Pharmacology |
Subjects: | |
Online Access: | http://www.joacp.org/article.asp?issn=0970-9185;year=2021;volume=37;issue=2;spage=160;epage=170;aulast=Shah |
_version_ | 1819151324678193152 |
---|---|
author | Shagun B Shah Uma Hariharan Rajiv Chawla |
author_facet | Shagun B Shah Uma Hariharan Rajiv Chawla |
author_sort | Shagun B Shah |
collection | DOAJ |
description | The corona virus disease 2019 (COVID-19) pandemic has till date (26/7/20) affected 1crore 62 lac 73 thousand 638 people globally with almost 6.5 lakh mortalities. COVID-19 has invaded the operation theatre and intensive care unit (ICU) in a short span of 6 months. It appears inevitable that all of us, as anesthesiologists, have to treat COVID-positive patients, either in the ICU or the operation theatre. Many asymptomatic, presumably noninfected people including frontline health care workers are also consuming potential anticorona viral drugs (such as hydroxychloroquine) prophylactically and may present for surgery. Detailed knowledge of which anesthetic and perioperative care drugs can interact with anti-COVID drugs would be very valuable for pre, intra-, and postoperative management of such patients and COVID-19 positive patients requiring intubation, mechanical ventilation, and ICU-sedation. Powered with this knowledge, anesthesiologists and intensivists can minimize the adverse effects of drug interactions. An extensive literature search using different search engines including Cochrane, Embase, Google Scholar, Scopus, and PubMed for all indexed review articles, original articles, case reports, and referenced webpages was performed to extract the most current and relevant literature on drug-drug interactions for clinicians. |
first_indexed | 2024-12-22T14:31:35Z |
format | Article |
id | doaj.art-c1c1e54a4639423987984e9fc65c6383 |
institution | Directory Open Access Journal |
issn | 0970-9185 |
language | English |
last_indexed | 2024-12-22T14:31:35Z |
publishDate | 2021-01-01 |
publisher | Wolters Kluwer Medknow Publications |
record_format | Article |
series | Journal of Anaesthesiology Clinical Pharmacology |
spelling | doaj.art-c1c1e54a4639423987984e9fc65c63832022-12-21T18:22:45ZengWolters Kluwer Medknow PublicationsJournal of Anaesthesiology Clinical Pharmacology0970-91852021-01-0137216017010.4103/joacp.JOACP_461_20Common anti-COVID-19 drugs and their anticipated interaction with anesthetic agentsShagun B ShahUma HariharanRajiv ChawlaThe corona virus disease 2019 (COVID-19) pandemic has till date (26/7/20) affected 1crore 62 lac 73 thousand 638 people globally with almost 6.5 lakh mortalities. COVID-19 has invaded the operation theatre and intensive care unit (ICU) in a short span of 6 months. It appears inevitable that all of us, as anesthesiologists, have to treat COVID-positive patients, either in the ICU or the operation theatre. Many asymptomatic, presumably noninfected people including frontline health care workers are also consuming potential anticorona viral drugs (such as hydroxychloroquine) prophylactically and may present for surgery. Detailed knowledge of which anesthetic and perioperative care drugs can interact with anti-COVID drugs would be very valuable for pre, intra-, and postoperative management of such patients and COVID-19 positive patients requiring intubation, mechanical ventilation, and ICU-sedation. Powered with this knowledge, anesthesiologists and intensivists can minimize the adverse effects of drug interactions. An extensive literature search using different search engines including Cochrane, Embase, Google Scholar, Scopus, and PubMed for all indexed review articles, original articles, case reports, and referenced webpages was performed to extract the most current and relevant literature on drug-drug interactions for clinicians.http://www.joacp.org/article.asp?issn=0970-9185;year=2021;volume=37;issue=2;spage=160;epage=170;aulast=Shahanesthetic drugsazithromycincovid-19dexamethasonefavipiravirhydroxychloroquineivermectinnitazoxanideremdesivirritonavirtocilizumab |
spellingShingle | Shagun B Shah Uma Hariharan Rajiv Chawla Common anti-COVID-19 drugs and their anticipated interaction with anesthetic agents Journal of Anaesthesiology Clinical Pharmacology anesthetic drugs azithromycin covid-19 dexamethasone favipiravir hydroxychloroquine ivermectin nitazoxanide remdesivir ritonavir tocilizumab |
title | Common anti-COVID-19 drugs and their anticipated interaction with anesthetic agents |
title_full | Common anti-COVID-19 drugs and their anticipated interaction with anesthetic agents |
title_fullStr | Common anti-COVID-19 drugs and their anticipated interaction with anesthetic agents |
title_full_unstemmed | Common anti-COVID-19 drugs and their anticipated interaction with anesthetic agents |
title_short | Common anti-COVID-19 drugs and their anticipated interaction with anesthetic agents |
title_sort | common anti covid 19 drugs and their anticipated interaction with anesthetic agents |
topic | anesthetic drugs azithromycin covid-19 dexamethasone favipiravir hydroxychloroquine ivermectin nitazoxanide remdesivir ritonavir tocilizumab |
url | http://www.joacp.org/article.asp?issn=0970-9185;year=2021;volume=37;issue=2;spage=160;epage=170;aulast=Shah |
work_keys_str_mv | AT shagunbshah commonanticovid19drugsandtheiranticipatedinteractionwithanestheticagents AT umahariharan commonanticovid19drugsandtheiranticipatedinteractionwithanestheticagents AT rajivchawla commonanticovid19drugsandtheiranticipatedinteractionwithanestheticagents |